Ovarian cancer is the sixth diagnosed cancer among women worldwide, it has a high mortality and in most cases it's diagnosed in advanced stage (stage III-IV). Combination platinum-paclitaxel chemotherapy administered every 3 weeks is considered the gold standard for first-line treatment of patients with advanced ovarian cancer. Elderly patients with ovarian cancer represents a subgroup with poor prognosis because they are often treated less radically for comorbidities and age. In the present article, we report a case of a 85 year old woman who was diagnosed with stage IV ovarian carcinoma for the presence of peritoneal carcinomatosis ab initio, not radically debulked and then treated with weekly schedule platinum-based and paclitaxel. Despite not being able to complete the chemotherapy, the patient achieved excellent results and represents a case of long survival.

[Long-term survival metastatic ovarian cancer elderly patient] / Amoroso, L; DE IULIIS, Francesca; Taglieri, Ludovica; Vendittozzi, Stefania; Salerno, G; Blasi, L; Lanza, R.. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - 165:6(2014), pp. 305-308.

[Long-term survival metastatic ovarian cancer elderly patient]

Taglieri, Ludovica;Salerno, G;
2014

Abstract

Ovarian cancer is the sixth diagnosed cancer among women worldwide, it has a high mortality and in most cases it's diagnosed in advanced stage (stage III-IV). Combination platinum-paclitaxel chemotherapy administered every 3 weeks is considered the gold standard for first-line treatment of patients with advanced ovarian cancer. Elderly patients with ovarian cancer represents a subgroup with poor prognosis because they are often treated less radically for comorbidities and age. In the present article, we report a case of a 85 year old woman who was diagnosed with stage IV ovarian carcinoma for the presence of peritoneal carcinomatosis ab initio, not radically debulked and then treated with weekly schedule platinum-based and paclitaxel. Despite not being able to complete the chemotherapy, the patient achieved excellent results and represents a case of long survival.
2014
Carboplatin; Elderly patient; Metastatic disease; Ovarian cancer; Paclitaxel; Peritoneal carcinosis
01 Pubblicazione su rivista::01a Articolo in rivista
[Long-term survival metastatic ovarian cancer elderly patient] / Amoroso, L; DE IULIIS, Francesca; Taglieri, Ludovica; Vendittozzi, Stefania; Salerno, G; Blasi, L; Lanza, R.. - In: LA CLINICA TERAPEUTICA. - ISSN 1972-6007. - 165:6(2014), pp. 305-308.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/868411
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact